ORAL L-HISTIDIN ZUR BEHANDLUNG ODER PRÄVENTION DER ATOPISCHEN DERMATITIS ODER KONTAKTDERMATITIS
European patent · EP2254575 · In force
Register entry
- Publication number
- EP2254575
- Application number
- EP09712628
- Kind
- European patent with effect for Switzerland and Liechtenstein
- Status
- In force
- Specification
- Granted
- Filed
- Feb 18, 2009
- Published
- Dec 1, 2010
- Granted
- May 4, 2016
- Protection ends at the latest
- Feb 17, 2029
- Next annual fee due
- Feb 28, 2027
- IPC classes
- A61K 31/4172 (2006.01)
- Priority
- GB 0803054 20.02.2008
- PCT application
- PCT/GB2009/000430 18.02.2009
- PCT publication
- WO2009/103959 27.08.2009
- Filing language
- English
- Source
- Swissreg
History
What the Federal Institute of Intellectual Property published about this title, newest first.
- Aug 18, 2026
Next annual fee due on
- Next annual fee due on
- 28.02.2026 → 28.02.2027
Published in Swissreg on 18.08.2026
- Aug 1, 2025
Next annual fee due on
- Next annual fee due on
- 28.02.2025 → 28.02.2026
Published in Swissreg on 01.08.2025
- Jul 23, 2024
Change
Published in Swissreg on 23.07.2024
- Mar 6, 2023
Change
Published in Swissreg on 06.03.2023
- Sep 23, 2021
Transferred
- Owner
- The University Of Manchester, Oxford Road, Manchester M13 9PL, United Kingdom → Curapel (Scotland) Limited, 272 Bath Street, Glasgow G2 4JR, United Kingdom
Published in Swissreg on 23.09.2021
- Aug 3, 2016
Agent entered
- Representative
- Schmauder & Partner AG, Patent- und Markenanwälte VSP, Zwängiweg 7, 8038 Zürich
Published in Swissreg on 03.08.2016
- May 4, 2016
Granted
Published in Swissreg on 04.05.2016
Parties
Agent
Inventor
GIBBS, Neil, Kerslake
Cheshire CW4 8BY, GB
The register names each party by name and address. A holder or agent is linked to an organization where exactly one entity of the commercial register bears its name; the street of a party not so recognised is not shown here.